Sofosbuvir (brand name Sovaldi) is a new medication used to treat hepatitis C. It was approved in Europe in January 2014 for treatment of adults with all genotypes of chronic hepatitis C. For some people, sofosbuvir will be the first interferon-free hepatitis C treatment option. For others, sofosbuvir can greatly shorten treatment when added to pegylated interferon and ribavirin. Successful treatment reduces the risk of long-term complications of hepatitis C such as liver cancer or needing a liver transplant.
Member Since 11 Years
Nature of Business Retailer
GST No. 09AUVPG8371K1ZQ
For Buyer 
For Seller 
Help 
Daryaganj, Delhi 
Send Enquiry